J Nanoneurosci. 2009 Jun 1;1(1):42-55.
Liu G, Men P, Perry G, Smith MA.
Department of Radiology, University of Utah, Salt Lake City, UT 84108, USA.
Keywords: Alzheimer's disease (AD), blood-brain barrier, nanoparticle-mediated drug delivery, chelation agents, iron-associated neurodegenerative diseases, Friedreich's ataxia, Parkinson's disease, Huntington's disease, Hallervorden-Spatz Syndrome, nanoparticle technology, very early stages of development.
Thursday, November 26, 2009
Clinical aspects of coenzyme Q(10): An update.
Nutrition. 2009 Nov 20.
Littarru GP, Tiano L.
Department of Biochemistry, Biology and Genetics, Polytechnic University of the Marche, Ancona, Italy.
Keywords: Q(10) (CoQ(10)), in mitochondrial bioenergetics, antioxidant properties, clinical applications, cardiovascular disease, physical exercise, mitochondrial myopathies, Parkinson's and Huntington's diseases, Friedreich's ataxia, preeclampsia in pregnancy. headache symptoms, pediatric and adolescent populations.
Littarru GP, Tiano L.
Department of Biochemistry, Biology and Genetics, Polytechnic University of the Marche, Ancona, Italy.
Keywords: Q(10) (CoQ(10)), in mitochondrial bioenergetics, antioxidant properties, clinical applications, cardiovascular disease, physical exercise, mitochondrial myopathies, Parkinson's and Huntington's diseases, Friedreich's ataxia, preeclampsia in pregnancy. headache symptoms, pediatric and adolescent populations.
Subscribe to:
Posts (Atom)
